Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Mateusz Hasso-Agopsowicz is a Technical Officer in the Department of Immunization, Vaccines and Biologicals (IVB) at the World Health Organization (WHO). He holds a PhD in Vaccine Immunology from the London School of Hygiene and Tropical Medicine (LSHTM). Mateusz leads theme areas on the role of vaccines in reducing antimicrobial resistance (AMR), development of vaccine-microarray patches (MAPs) and enteric vaccines at the WHO. His work prioritises and facilitates the development of vaccines and delivery systems that will be readily used in low- and middle-income countries (LMICs).  Dr Mateusz has assessed the pipeline of vaccines in development and their value to reduce AMR to inform vaccine prioritisation during development, introduction, and use, and the selection of vaccines for the Gavi Vaccine Investment Strategy. He has also published and disseminated the WHO's strategy on leveraging vaccines to reduce AMR and antibiotic use. His research activities for vaccines with potentially high impact on AMR include research roadmaps, value proposition assessments, and documents summarising vaccines preferred product characteristics. 

Summary of talk:  

  • The burden of AMR,  
  • The mechanisms through which vaccines can prevent AMR 
  • WHO strategies and analyses to better understand the impact of vaccines on AMR;  
  • Evidence from observational studies and clinical trials on vaccine impact on AMR; 
  • Evidence from modelling analyses on vaccine impact on AMR.

 

MEMBERS OF THE UNIVERSITY ONLY.

Forthcoming events

Gut microbiome

Monday, 28 April 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Malaria and febrile coma cohort study

Monday, 12 May 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

The meningococcal B vaccine journey and beyond

Monday, 19 May 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Avian and human influenza

Monday, 02 June 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Better treatment for tuberculosis

Monday, 09 June 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

The burden of drug resistant infections, the GRAM project

Monday, 16 June 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms